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Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: ev- idence for early programming involving the androgen receptor Using DNA microarrays representing 32,968 different genes, we identified 404 transcripts with significant differences in transcription lev- els between genital skin fibroblasts cultured from normal and AIS-affected individuals. Gene-cluster analyses uncovered coordinated ex- pression of genes involved in key processes of morphogenesis. On the basis of animal studies and human genetic syndromes, several of  these genes are known to have specific roles in genital differentiation. Remarkably, genital fibroblasts from both normal and AIS-affected  individuals showed no transcriptional response to dihydrotestosterone treatment despite expression of the AR.
Abstract
Background: Androgen insensitivity syndrome (AIS) comprises a range of phenotypes from male
infertility to complete feminization. Most individuals with AIS carry germline mutations of the
androgen receptor (AR) that interfere with or ablate its function. As genital fibroblasts retain
expression of the AR in vitro, we used genital skin fibroblasts from normal males and 46,XY females
with complete AIS due to known AR mutations to gain insights into the role of the AR in human
genital differentiation.
Results:  Using DNA microarrays representing 32,968 different genes, we identified 404
transcripts with significant differences in transcription levels between genital skin fibroblasts
cultured from normal and AIS-affected individuals. Gene-cluster analyses uncovered coordinated
expression of genes involved in key processes of morphogenesis. On the basis of animal studies and
human genetic syndromes, several of these genes are known to have specific roles in genital
differentiation. Remarkably, genital fibroblasts from both normal and AIS-affected individuals
showed no transcriptional response to dihydrotestosterone treatment despite expression of the
AR.
Conclusions: The results suggest that in addition to differences in the anatomic origin of the cells,
androgen signaling during prenatal development contributes to setting long-lasting, androgen-
independent transcriptional programs in genital fibroblasts. Our findings have broad implications in
understanding the establishment and the stability of sexual dimorphism in human genital
development.
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Background
Development of the male genitalia is largely controlled by
cells in the urogenital mesenchyme that express androgen re-
ceptors (AR) [1,2]. Germline mutations of the AR gene pro-
duce a spectrum of developmental abnormalities in 46,XY
individuals ranging from infertility or mild hypospadias to
complete feminization, which are collectively referred to as
the androgen insensitivity syndrome (AIS). In general, the
degree of genital ambiguity correlates with the level of com-
promise of AR function: 46,XY individuals with AR-inactivat-
ing mutations are completely feminized despite high levels of
serum testosterone [3￿5].
The molecular events responsible for AR-dependent male
genital morphogenesis are poorly understood. We hypothe-
sized that the AR-dependent mesenchymal programs under-
lying male external genitalia development might be
illuminated by comparing the transcriptional profile of mes-
enchyme-derived stromal cells from normal males to those
from individuals affected with AIS. As cultured genital fibrob-
lasts originate from the urogenital mesenchyme and retain
expression of the AR in vitro, we compared gene-expression
patterns in cultured genital fibroblasts from normal 46,XY
males and from 46,XY females with severe or complete AIS,
using DNA microarrays representing 32,968 distinct human
genes. We found striking differences in the gene expression
profiles of genital fibroblasts cultured from normal and AIS
patients, but no transcriptional response to androgen was de-
tectable in any of the cultured genital fibroblasts.
Results
Baseline gene transcription in genital fibroblasts
To gain insights into the role of androgen in genital morpho-
genesis, we compared basal transcriptional patterns in geni-
tal fibroblasts from 46,XY individuals with either wild-type
AR or germline inactivation of the AR as a result of mutation.
We could not identify mutations in the AR gene in two pheno-
typically female individuals w i t h  c o m p l e t e  A I S .  H o w e v e r ,
genital skin fibroblasts of both subjects failed to express AR
protein and did not show androgen binding (Table 1). Initial-
ly, we restricted our analysis to genital skin fibroblasts grown
from the foreskin of nine normal males and from the labia
majora of five AIS-affected, 46,XY individuals with female ex-
ternal genitalia. The AR status of all genital fibroblasts was
confirmed by AR gene sequencing and hormone-binding as-
says (Table 1). To determine basal gene-expression patterns,
mRNA was isolated from growth-arrested (G0) confluent cells
and analyzed using DNA microarrays of approximately
43,000 cDNAs representing 32,968 genes. Distinct differenc-
es in the basal expression profiles of normal and AIS-derived
fibroblasts allowed these two groups to be distinguished on
the basis of their expression patterns by unsupervised hierar-
chical clustering analysis (Figure 1). We then identified 404
unique transcripts (represented by 487 total cDNAs) with sig-
nificant differences in expression levels between normal and
AIS genital fibroblasts using the significance analysis of
microarrays (SAM)-procedure [6], with a false discovery rate
o f  l e s s  t h a n  0 . 9 2 %  ( p e r c e n t  o f  g e n e s  i d e n t i f i e d  b y  c h a n c e
alone).
We used the list of the 487 cDNAs from the SAM analysis for
hierarchical clustering analysis of 24 different primary fibro-
blast lines from normal and AIS affected individuals (Figure
2). In addition to the 14 genital-skin fibroblast lines used to
generate the SAM list, we included five gonadal fibroblast
lines from 46,XY females with complete AIS, a prostate fibro-
blast cell line from a normal male (analyzed twice), abdomi-
nal skin fibroblasts from a normal male, forearm fibroblasts
Figure 1
Unsupervised hierarchical cluster analysis of genes and experiments of 
nine normal genital skin fibroblast lines (penile foreskin) and five AIS 
genital skin fibroblast lines (labia majora). Only transcripts whose log2 red/
green ratio differed from the mean expression level across all experiments 
by at least 1.1 in at least four experiments are displayed (620 cDNAs). The 
dendrogram of the array experiments (above and repeated on the left) 
reflects the similarity of the samples with respect to their gene-expression 
patterns. F, female external genitalia; M, normal male external genitalia; 
NORM, normal male control; AIS4, AIS with predominantly female 
phenotype (slight enlargement of the clitoris); CAIS, complete androgen-
insensitivity syndrome; GSF, genital skin fibroblast. Increasing red intensity 
corresponds to increased gene-expression levels compared to the mean 
log2 red/green ratio for each gene; increasing green intensity corresponds 
to decreased gene-expression levels. The scale ranges from -8 to +8 in 
log2 space.http://genomebiology.com/2003/4/6/R37 Genome Biology 2003,     Volume 4, Issue 6, Article R37       Holterhus et al. R37.3
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from a normal male, and genital fibroblasts from two AIS
46,XY females who had documented AR mosaicism
(ARD364, ARD 465, Table 1). The ARD364 and ARD465 lines
express wild-type AR and were derived from individuals who
were mosaics for wild-type AR and AR with a premature stop
codon [7]. Hierarchical cluster analysis, based on the expres-
sion of 472 of the 487 previously identified transcripts with
measurable expression across at least 80% of 24 experiments,
separated the fibroblasts into those with gene-expression pat-
terns resembling normal male foreskin fibroblasts and a sec-
ond group with an expression pattern more similar to labial
skin fibroblasts from AIS-affected individuals (Figure 2). The
latter group contained all five gonadal fibroblast lines from
complete AIS females as well as the fibroblast lines from
abdominal and forearm skin. The prostate fibroblasts, on the
other hand, displayed expression patterns largely similar to
the normal male foreskin cells. Notably, the two mosaic AIS
cell lines ARD364 and ARD465 showed gene-expression pat-
terns that most resembled normal male foreskin (Figure 2).
Comparison of expression patterns in genital fibroblasts from
normal and AIS-affected individuals, and fibroblasts from ex-
tragenital sites, offers possible insights into the programs that
underlie genital development. For instance, transcripts en-
coding homeobox A13 protein (HOXA13) and T-box proteins
(TBX) showed striking differences in their expression levels
between the ’male genital’ and ’AIS/extragenital’ fibroblasts.
HOXA13 was expressed at high levels in normal male foreskin
Table 1
Cell strains
Cell strain Subtype, origin External genitalia/
phenotype
Age at biopsy
(years; months)
Androgen receptor
N-33 GSF, foreskin Normal fertile male 51;11 Normal (Kd 0.08 nM, Bmax 26.40 fmol/mg protein)
N-40 GSF, foreskin Normal male 7;11 Normal (Kd 0.09 nM, Bmax 32.44 fmol/mg protein)
N-52 GSF, foreskin Normal male 0;3 Normal (Kd 0.06 nM, Bmax 35.36 fmol/mg protein)
N-56 GSF, foreskin Normal fertile male 42;10 Normal (Kd 0.07 nM, Bmax 13.35 fmol/mg protein)
N-57 GSF, foreskin Normal male 5;11 Normal (Kd 0.05 nM, Bmax 24.13 fmol/mg protein)
N-58 GSF, foreskin Normal male 5;11 Normal (Kd 0.10 nM, Bmax 30.61 fmol/mg protein)
N-59 GSF, foreskin Normal male 0;8 Normal (Kd 0.07 nM, Bmax 40.01 fmol/mg protein)
N-60 GSF, foreskin Normal male 5;4 Normal (Kd 0.05 nM, Bmax 20.08 fmol/mg protein)
N-62 GSF, foreskin Normal male 2;0 Normal (Kd 0.08 nM, Bmax 86.16 fmol/mg protein)
N-AKPZF PRF, peripheral zone Normal male Adult Not investigated
N-ST4 ASF, abdominal skin Normal male 46;0 Not investigated
N-LS12 FSF, forearm skin Normal male 36;0 Not investigated
ARD1097 GSF, labia majora Normal female 1;3 CAIS, Pro390Ser + Arg855Gly, negative androgen binding
ARD411 GSF, labia majora Normal female 0;4 CAIS, Arg855Cys, negative androgen binding
ARD682 GSF, labia majora Normal female 14;10 CAIS, no mutation in AR-gene, negative androgen binding, no 
AR-protein in western immunoblot
ARD402 GSF, labia majora Normal female 1;0 CAIS, no mutation in AR-gene, negative androgen binding, very low 
AR-mRNA transcription, no AR-protein in western immunoblot
ARD377 GSF, labia majora Predominantly 
female
1;2 AIS4, Ile841Ser, (Kd 0.55 nM; Bmax 17.01 fmol/mg protein)
ARD842 GOF, gonad Normal female 38;0 CAIS, 26 bp deletion exon 1 (141-150), frameshift, premature stop 
codon, negative androgen binding
ARD1004 GOF, gonad Normal female 17;4 CAIS, Val866Met, negative androgen binding
ARD291 GOF, gonad Normal female 18;4 CAIS, Phe794Ser, negative amdrogen binding
ARD531 GOF, gonad Normal female 35,2 CAIS, Ala765Thr, negative androgen binding
ARD557 GOF, gonad Normal female 6;6 CAIS, donor splice site exon 2/intron 2, negative androgen binding
ARD465 GSF, labia majora Normal female 5;5 CAIS, Glu287stop, low expression of wild-type AR (Kd 0.11 nM; Bmax 
3.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism)
ARD364 GSF, labia majora Predominantly 
female
23;0 AIS4, Leu 172 stop, high expression of wild-type AR (Kd 0.06 nM, Bmax 
22.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism) (6)
ARD, strain-ID; ASF, abdominal skin fibroblast; FSF, forearm skin fibroblast; GOF, gonadal fibroblast; GSF, genital skin fibroblast; PRF, prostate 
fibroblast. Normal ranges for androgen (methyltrienolone) binding: Bmax (binding capacity): 13.35-115.98 fmol/mg protein; Kd (dissociation constant): 
0.03-0.13 nM.R37.4 Genome Biology 2003,     Volume 4, Issue 6, Article R37       Holterhus et al. http://genomebiology.com/2003/4/6/R37
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fibroblasts and at low levels in all AIS and extragenital fibrob-
lasts (Figure 2). T-box gene 3 (TBX3) was expressed at higher
levels in the fibroblasts from genital skin, extragenital skin or
prostate from males than in genital skin fibroblasts from AIS
46,XY females (Figure 2). TBX2 showed an almost identical
expression profile to TBX3, whereas high TBX5 expression
appeared to be restricted to foreskin fibroblasts from normal
males (including those from the phenotypically female mosa-
ic patient ARD364). BMP4 (bone morphogenetic protein 4)
was predominantly expressed in foreskin fibroblasts from
normal males and in prostate fibroblasts (Figure 2). WNT2
(wingless-type MMTV integration site family member 2) was
part of a small gene cluster with high expression in normal
male foreskin fibroblasts that distinguished these samples
from all other fibroblasts (Figure 2).
Compared to genital and gonadal fibroblasts from 46,XY fe-
males, fibroblasts from normal male genital tissues showed
pronounced differences in expression of cell adhesion and ex-
tracellular matrix genes. For example, cadherin 13 (CDH13),
versican (CSPG2), collagen 8A1 (COL8A1), collagen 12A1
(COL12A1), P4HA2 (encoding a procollagen-modifying en-
zyme) all showed relatively low expression in the genital skin
fibroblasts of normal males, whereas tenascin XB (TNXB), ni-
dogen 2 (NID2), laminins (LAMA3, LAMA4) and tissue in-
hibitor of metalloproteinase 1 (TIMP1) all showed relatively
high expression levels compared to AIS-derived fibroblasts
(Figure 2). Several of the differentially expressed genes, in-
cluding aldo-keto reductase 1C1 (AKR1C1), aldehyde dehy-
drogenase 1A1 (ALDH1A1), and alcohol dehydrogenase 1B
(ADH1B), function in sex steroid and retinoic acid
Figure 2
Hierarchical cluster analysis of genes and experiments based on cDNAs identified as being significantly different in expression between normal genital skin 
fibroblasts and genital skin fibroblasts of female patients with AIS. The left panel shows an overview of 472 of the total of 487 significant transcripts that 
showed measurable expression across at least 80% of 24 experiments. The color code of the dendrogram and the sample names represent the origin of 
the fibroblast strains. GSF, genital skin fibroblast; PRF, prostate fibroblast; GOF, gonadal fibroblast; FSF, forearm skin fibroblast; ASF, abdominal skin 
fibroblast; other abbreviations are as in Figure 1 and Table 1. The scale ranges from -4 to +4 in log2 space. For the complete dataset, see Additional data 
files and [36].
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metabolism (Figure 2). Other differentially expressed genes,
such as mitogen-activated protein kinase 14 (MAP3K14), and
STAT-induced STAT inhibitors 2 and 3 (STATI2, SSI-3), en-
code proteins involved in intracellular signal transduction.
Transcriptional response of cultured genital fibroblasts 
to androgen treatment
We tested the responses of normal and AIS genital fibroblasts
to dihydrotestosterone (DHT), under culture conditions sim-
ilar to those that were reported to produce aromatase induc-
tion in these cells [8]. Cells were treated with DHT (100-
1,000 nM) both at confluency (G0) and during exponential
growth, and transcript levels were assessed using DNA micro-
arrays. Unsupervised hierarchical clustering did not disclose
any obvious differences in gene-expression patterns between
DHT-treated and ethanol-treated fibroblasts, either in nor-
mal controls or in AIS-derived cell lines. We treated LNCaP
prostate cancer cells with androgen under similar conditions
and readily identified nearly 500 transcripts modulated by
androgen with unsupervised hierarchical clustering analysis
and with supervised methods ([9] and data not shown). A su-
pervised analysis comparing gene-expression patterns of
DHT-treated fibroblasts to ethanol-treated controls was car-
ried out using the SAM procedure. Again, no genes could be
identified that were significantly induced or repressed by
DHT treatment. Additional experiments using physiological
concentrations of androgen (for example, 0.01 - 1 nM methyl-
trienolone) also failed to disclose any androgen-responsive
genes (data not shown). In contrast, SAM analysis identified
1,664 transcripts that differed significantly between prolifer-
ating and confluent cells, and 1,232 transcripts that differed
between fibroblasts derived from AIS-affected individuals
and normal male foreskin. Hierarchical cluster analysis of
these experiments clearly showed the distinct differences in
transcriptional profiles between AIS-derived and normal
male fibroblasts and between proliferating and normal fi-
broblasts (Figure 3). Cells derived from the same individual
and cultured under the same conditions always showed high-
ly similar gene-expression patterns, suggesting that the dif-
ferences in expression between individuals are stable and
reproducible despite passage in vitro (Figure 3).
Discussion
We found consistent, characteristic differences in baseline
gene expression patterns between genital skin fibroblasts
from normal males and 46,XY female patients with AIS.
Many of these differences between normal and AIS-derived
fibroblasts were also observed in gonadal fibroblasts, sug-
gesting that these differences are not purely due to differ-
ences in the anatomical site of origin of the fibroblasts.
Interestingly, fibroblasts derived from abdominal and fore-
arm skin, regions with relatively little sexual dimorphism,
showed gene-expression patterns similar to the labial skin
fibroblasts of AIS patients. Together, these data suggest that
the AR is involved in determining a stable and stereotypical
program of gene expression in genital fibroblasts that does
not require the continuing presence of androgen for its
maintenance.
A critical question raised by these results is whether the ob-
served differences between genital fibroblasts from males and
AIS females reflect cell-autonomous effects of androgen ex-
posure during development, or indirect effects of the AR-de-
pendent genital morphogenetic program. One possible
interpretation of these data is that the distinct patterns of ex-
pression could have been due to differences in the origin or
the developmental milieu of foreskin fibroblasts, derived
from the genital tubercle, as opposed to the labial fibroblasts,
derived from the genital swellings [10]. The differences in
gene expression we observed in AIS fibroblasts of gonadal or-
igin compared to those of labial origin support this view (Fig-
ure 3). We have observed consistent and characteristic
differences in the gene-expression patterns of skin fibroblasts
derived from different locations on the body [11]. However,
the current set of experiments suggests that the androgen re-
ceptor has a cell-autonomous role which contributes to a sta-
ble androgen-independent gene-expression pattern in genital
fibroblasts. Expression patterns in cultured labial skin fibrob-
lasts derived from two different individuals with AR mosai-
cism suggested that the cell-autonomous AR status was a
relevant determinant of baseline gene expression in genital
skin fibroblasts. Both these fibroblast lines, although derived
from morphologically female genitalia in phenotypically fe-
male 46,XY individuals mosaic for AR-inactivating muta-
tions, expressed wild-type AR in the cultured cells. These
female AIS-affected individuals are thought to have acquired
their  AR  gene mutations post-zygotically [12]. ARD364,
which showed AR protein expression and binding in the
range of normal male foreskin fibroblasts ([7] and see Table
1), despite its origin from anatomically female genitalia, had a
gene-expression pattern indistinguishable from foreskin fi-
broblasts of normal males (Figure 2). The second fibroblast
line from an AR mosaic patient, ARD465 (Table 1), had very
low wild-type AR expression and showed baseline gene-ex-
pression patterns that were nevertheless more similar to nor-
mal male foreskin and prostate fibroblasts than to any of the
AIS-derived cell lines (Figure 2).
The discrepancy between the female phenotype of these mo-
saic individuals despite expression of the wild-type AR in cul-
tured genital skin fibroblasts is not resolved to date [7]. It may
be explained by a time-dependent rise of an originally small
fraction of cells containing the wild-type AR allele in the mo-
saic genital mesenchyme during prenatal and postnatal de-
velopment, or by differences between in vivo and in vitro
conditions. Yet, the documented expression of the wild-type
AR in cultures of these labial cells supports the idea that the
AR status of the fibroblast was an important intrinsic deter-
minant of the basal transcription patterns we identified.
Therefore, the AR appears to be involved in setting long-last-
ing gene-expression patterns in genital skin fibroblasts.R37.6 Genome Biology 2003,     Volume 4, Issue 6, Article R37       Holterhus et al. http://genomebiology.com/2003/4/6/R37
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Comparison of gene-expression patterns in genital fibroblasts
from normal and AIS-affected individuals, and in fibroblasts
from extragenital sites, may offer clues to the programs that
underlie external genital development. Both cell adhesion
and connective tissue remodeling are indispensable for
normal development and maintenance of tissue integrity [13￿
15]. The differential expression of proteoglycans, collagens
and cell adhesion molecules (for example cadherin 13) might
be involved in genital morphogenesis and later stability of
sexually dimorphic traits of the external genitalia. Some
genes expressed in wild-type AR cells could influence andro-
gen signaling. For instance, aldo-keto reductase 1C1 is
specifically involved in cellular androgen metabolism [16]
and thus may modulate the spectrum of cellular androgenic
steroids available for activation of the AR. Structurally differ-
ent androgens elicit different patterns of response from sev-
eral androgen-responsive promoters, suggesting that the type
of ligand present could affect cellular response [17]. Mitogen-
activated protein kinase 14, and STAT-induced STAT inhibi-
tors 2 and 3 were expressed at significantly higher levels in
cells with wild-type AR. Both MAP kinase and STAT pathways
are involved in AR-dependent regulation and in ligand-inde-
pendent activation of the AR [18]. Differential expression of
aldehyde dehydrogenase 1A1 and alcohol dehydrogenase 1B,
Figure 3
Hierarchical cluster analysis of genes and experiments with different DHT-treatment regimens. Shown are 686 transcripts whose log2 red/green ratio 
differed from the mean expression level across all experiments by at least 1.5 in at least three experiments. The analysis is based on 2,862 transcripts 
identified by SAM analysis that distinguish between normal genital skin fibroblasts and gonadal fibroblasts from 46,XY female AIS patients, and between 
proliferating and confluent fibroblasts. The color code in the dendrogram depicts the origin of the fibroblast cultures. The gray and white bars at the top 
of the cluster indicate the proliferation state of the samples. On the right, the regions of the cluster diagram that differentiate between normal and AIS-
derived fibroblasts, and proliferating and confluent cells, respectively, are indicated. No differences in transcript levels could be discerned between DHT-
treated and control cells in either normal foreskin fibroblasts or fibroblasts from AIS-affected 46,XY females. Abbreviations are as in Figure 2 and Table 1. 
The scale ranges from -8 to +8 in log2 space. For the dataset of 686 genes used for the cluster analysis and the complete dataset of 2,862 genes, see 
Additional data files and [36].
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enzymes that affect retinoic acid biosynthesis, suggest that
other signaling pathways may participate in the AR-initiated
programs of external genital differentiation [19,20].
Several genes expressed specifically in the normal male fore-
skin fibroblasts have been previously implicated in male gen-
ital development, including HOXA13, the T-box genes, BMP4
and DWnt2. Mutations in HOXA13 can cause distal limb and
urogenital-tract malformations such as male hypospadias in
hand-foot-genital syndrome [21]. T-box genes (TBX) are es-
sential early regulators of limb development and also appear
to be involved in male genital development [22,23]. Muta-
tions in TBX3 cause the ulnar-mammary syndrome charac-
terized by limb, apocrine, and genital developmental
abnormalities [23]. Expression of T-box genes 2, 3, and 5 was
significantly higher in normal male foreskin fibroblasts than
in AIS genital fibroblasts. BMP4 has been implicated in ductal
budding and branching during prostate development [24]
and a potential role of BMP4 in external genital development
has also been postulated [25]. DWnt2 has been found to have
roles in sex-specific cell determination in the gonads and gen-
ital disc of Drosophila [26]. Thus, mutations in genes charac-
teristically expressed in normal male foreskin fibroblasts can,
in some cases, lead to defective genital development. The data
from these experiments therefore provide candidate genes for
further investigation in patients with genital malformations.
As normal genital skin fibroblasts of 46,XY male individuals
express the AR in vitro (see Table 1 and [4,7]), we had antici-
pated that androgen treatment would elicit a transcriptional
response program that could provide additional insights into
the role of androgen in genital development. We have previ-
ously used a similar approach to delineate the transcriptional
programs activated in prostate cancer cells in response to an-
drogen [9]. We had hoped that comparison of transcriptional
responses of normal fibroblasts to those from AIS-affected in-
dividuals with varying degrees of genital ambiguity would
provide still further insights into androgen’s role in genital
morphogenesis. However, we were unable to detect any sig-
nificant changes in gene-expression patterns in cultured, AR-
expressing genital fibroblasts or in AIS-derived fibroblasts in
response to androgens. Although two previous reports have
shown increases in aromatase enzymatic activity in genital
skin fibroblasts treated with dihydrotestosterone (DHT)
[8,27], others have failed to observe changes in aromatase ac-
tivity in response to androgen [28]. In agreement with our
findings, Elmlinger et al. found significantly different base-
line expression levels of insulin-like growth factor (IGF) and
insulin-like growth factor binding protein (IGFBP) between
normal and AIS-derived genital skin fibroblasts, and could
not detect changes in transcript levels in response to andro-
gen treatment [29]. In normal genital fibroblasts, androgen-
responsive reporter genes can only be activated by expression
of co-transfected AR in the presence of ligand [30]. Therefore,
endogenous AR expression itself may be insufficient in geni-
tal skin fibroblasts to elicit a transcriptional response.
Moreover, the lack of detectable changes in transcript levels
for any of the 30,000 genes in the AIS-fibroblasts virtually ex-
cludes the possibility that DHT or R1881 could be acting
through other steroid receptors or other signaling pathways.
The differences in androgen responsiveness we have ob-
served between normal genital fibroblasts and prostate can-
cer epithelial cells in vitro might reflect the responses seen in
vivo. Prostate epithelial cells retain exquisite sensitivity to an-
drogen throughout life. Androgen deprivation produces pro-
found involution of the prostate, particularly of the epithelial
component, but little or no change in the external genitalia. It
is possible that genital mesenchymal cells are only capable of
responding to androgen at discrete stages in development in
their specific in vivo environment. In mice, stromal androgen
responsiveness is restricted to the earliest stages in prostate
development, and later the epithelial compartment becomes
responsive and remains so [1]. This responsiveness may be
mediated through the expression of specific AR co-regulators.
Compared to LNCaP cells, normal male genital fibroblasts
show distinctly lower baseline expression of several AR co-
regulators (such as NCOA2 (GRIP-1), NCOA3 (TRAM-1),
ARA54 (RNF14), data not shown). Thus, genital fibroblasts
may express critical AR co-regulators at discrete times during
development that allow them to respond by setting up long-
lasting transcriptional programs that underlie the genesis
and maintenance of genital morphology.
Conclusions
Our data suggest that in addition to androgen-independent
positional influences on fibroblast phenotypes, the AR is orig-
inally involved in establishing stable and reproducible pat-
terns of gene expression in stromal cells during genital
differentiation, which are reflected in the differences in global
gene-expression patterns between fibroblasts cultured from
the genital skin of normal individuals and females affected by
AIS. Comparison of the expression patterns of genital fibrob-
lasts from 46,XY normal males and 46,XY females with inac-
tivated AR provides a window on the AR-dependent gene-
expression programs within the urogenital mesenchyme,
which contribute to the development and structural integrity
of male and female genitalia. For further discrimination of
androgen-independent positional effects from prenatal an-
drogen actions on expression phenotypes of genital fibroblast
strains, comparative expression profiling of homologous gen-
ital tissues is needed. The apparent lack of response of genital
fibroblasts to androgen in vitro, despite expression of a nor-
mal AR, has important implications for future research in de-
fining the role of androgen in genital development and the
pathogenesis of ambiguous genitalia. Transcriptional profil-
ing of the early stages of genital development in vivo in the
presence and absence of androgen may provide further in-
sights into the role of androgen in genital development.R37.8 Genome Biology 2003,     Volume 4, Issue 6, Article R37       Holterhus et al. http://genomebiology.com/2003/4/6/R37
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Materials and methods
The study was approved by the ethical committee of the Uni-
versity of L￿beck, Germany. Informed consent was obtained
from all normal subjects and AIS patients or their parents.
Cell strains
Primary cultures of genital fibroblasts were established from
genital skin biopsies (labia majora) or gonadal biopsies in fe-
male AIS patients and from the foreskin of normal males un-
dergoing circumcision. Abdominal skin fibroblasts were
derived from the midline above the mons pubis of a fertile
male during abdominal surgery. Forearm skin fibroblasts
from a normal male were a gift from H. Chang (Department
of Biochemistry, Stanford University). Peripheral zone pros-
tate fibroblasts were a gift from D. Peehl (Department of
Urology, Stanford University) and were established from a
histologically normal region of a patient undergoing prostate-
ctomy for prostate cancer who had not been previously
treated with hormonal therapy. Hormone-binding assays us-
ing methyltrienolone (R1881, 17β-hydroxy-17α-methyl-
4,9,11-estrotrien-3-one) and androgen receptor sequencing
have been described previously [7].
Cell culture and hormone treatment
For determination of basal gene-expression profiles without
androgen stimulation, fibroblasts were cultured on 150-mm
plastic dishes at 37￿C with 5% CO2. To eliminate possible ar-
tifacts due to differing states of proliferation, cells were grown
to confluence, at which point they enter G0 arrest [31]. They
were maintained in phenol-red-free DMEM F12 (Dulbecco’s
modified Eagle Medium with the nutrient mix F12; Gibco)
containing L-glutamine, 15 mM Hepes buffer, penicillin/
streptomycin (Gibco) and 12.9% of a constant lot of certified
fetal calf serum (FCS; Gibco). The pH was adjusted to 7.4 with
1 N NaOH and the medium was exchanged every 48 h. At day
13 the last media exchange was carried out and 96 h later cells
were scraped and mRNA harvested directly.
Androgen stimulation of genital fibroblasts was carried out
under two different culture conditions similar to those previ-
ously reported to produce induction of aromatase enzymatic
activity in these cell lines [8,27]. In the first, cells were grown
to confluence as described above using phenol-red-free
DMEM F12 containing L-glutamine, 15 mM Hepes buffer,
penicillin/streptomycin (Gibco) with 12.9% charcoal-
stripped, steroid-free FCS (D/S-FCS) (Hyclone) to ensure an-
drogen-depleted conditions in control cells. With every media
exchange every 48 h, cells received either ethanol in a final di-
lution of 1:100,000 or 100 nM dihydrotestosterone (DHT)
dissolved in ethanol. The last DHT treatment was
administered with the last media exchange 96 h before lysate
preparation. In total, six doses of either ethanol or 100 nM
DHT were given.
In the second set of experiments, cells were cultured to con-
fluence for 14 days as described above. They were then
trypsinized and seeded at a density of 3,000 cells per cm2 in
150-mm plates. Twenty-four hours later, medium was re-
moved, and cells were washed three times with new media
containing 12.9% D/S-FCS, then cultured for another 24-h in-
terval in the absence of androgens. Cells were then treated
with either 1:100,000 ethanol, 100 nM or 1,000 nM DHT dis-
solved in ethanol. After 24 h incubation, exponentially grow-
ing cells were harvested. LNCaP cells, passaged and treated
under similar conditions, were used as a positive control for
androgen reponsiveness.
RNA isolation and cDNA labeling
Protocols for mRNA preparation and cDNA labeling are avail-
able online [32]. mRNA (2 µg) from single experiments was
reverse transcribed and labeled with Cy5 (pseudo-coloured
red) and pooled reference mRNA was labeled with Cy3 (pseu-
do-coloured green). Reference mRNA contained equal mix-
tures of fibroblast mRNA (pooled from confluent and
proliferating cultures of normal and AIS genital skin fibrob-
lasts) and a ’common reference’ of mRNAs isolated from 11
different proliferating cultured tumor cell lines that we have
described previously [33].
Microarrays and hybridizations
Microarrays with approximately 43,000 sequence-validated
PCR-amplified human cDNAs representing 32,968 UniGene
clusters were manufactured as described [32]. Hybridizations
were performed using equal amounts of Cy3- and Cy5-labeled
cDNAs according to previously published protocols [32]. Hy-
bridized microarrays were scanned using a GenePix4000 ar-
ray scanner and analyzed with GenePix Pro 3.0 software
(Axon Instruments, Union City, CA).
Microarray data analysis
Only spots with fluorescence signals 1.5-fold greater than
background in either the experimental or reference samples
were included in the analysis. To correct for variations in
cDNA labeling efficiency, we normalized the Cy5/Cy3 fluores-
cence ratios for all genes in each array hybridization to obtain
an average log2 (ratio) of 0. We restricted our analysis to
genes with measurable expression in 80% of the samples we
analyzed. We used the SAM procedure [6] to identify genes
with statistically significant differences in baseline expression
levels between normal and AIS genital fibroblasts. The SAM
procedure computes a two-sample T-statistic (for example for
normal vs AIS cell lines) for the normalized log ratios of gene-
expression levels for each gene. It thresholds the T-statistics
to provide a ’significant’ gene list and provides an estimate of
the false discovery rate (the percent of genes identified by
chance alone) from randomly permuted data. Gene-expres-
sion data were clustered [34,35] and results were visualized
using TreeView software [35].
To identify the effects of androgen treatment on gene expres-
sion in genital fibroblasts, we carried out a set of 21 DNA
microarray analyses of mRNA from normal and AIS genitalhttp://genomebiology.com/2003/4/6/R37 Genome Biology 2003,     Volume 4, Issue 6, Article R37       Holterhus et al. R37.9
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fibroblasts. This dataset included cells treated at confluence
(G0) or during exponential proliferation as described above.
Raw data were filtered, normalized and centered as described
above. We used the SAM procedure to identify transcripts
with significant differences in expression with reference to
the origin of the fibroblast lines, whether the cells were con-
fluent or proliferating, and whether they had been treated
with androgen.
Additional data files
The following files are available with the online version of this
paper: a figure  (Additional data file 1) showing the complete
dataset for Figure 1, with associated array tree correlations
(atr), complete data table (cdt) and gene tree correlations
(gtr) files (Additional data files 2, 3 and 4); a figure (Addition-
al data file 5) showing the complete dataset for Figure 2, with
associated atr, cdt and gtr files (Additional data files 6, 7 and
8); a figure (Additional data file 9) showing the complete da-
taset for Figure 3, with associated atr, cdt and gtr files (Addi-
tional data files 10, 11 and 12). Figure 3 contains 686
transcripts whose log2 red/green ratio differed from the mean
expression level across all experiments by at least 1.5 in at
least three experiments of the treatment series. The analysis
was based on 2,862 transcripts that differed significantly be-
tween proliferating and confluent cells and between fibrob-
lasts derived from AIS-affected individuals and normal male
foreskin, respectively, as identified by SAM analysis of the
treatment series. The complete 2,862 genes are displayed in
two further figures (Additional data files 13 and 14) with asso-
ciated atr, cdt and gtr files (Additional data files 15, 16 and 17).
All files are also available online at [36].
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